RYOGEN LLC has a total of 21 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are CHANT JOHN, GENOPIA BIOMEDICAL GMBH and RYAN JAMES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 21 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Measuring microorganism processes | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Unspecified technologies | |
#6 | Therapeutic chemical compounds | |
#7 | Enzymes | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Ryan James | 12 |
#2 | Ryan James W | 9 |
Publication | Filing date | Title |
---|---|---|
US7985571B1 | Isolated genomic polynucleotide fragments from chromosome 17 that encode human carboxypeptidase D | |
US7470522B1 | Isolated genomic polynucleotide fragments encoding human resistin and the human syntaxin binding protein 2 | |
US7754424B1 | Isolated genomic polynucleotide fragments from chromosome 12 that encode human carboxypeptidase M and the human mouse double minute 2 homolog | |
US7273718B1 | Isolated genomic polynucleotide fragments from chromosome 10q25.3 that encode human soluble aminopeptidase P | |
US8039602B2 | Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |